Delivery Order SPE2DB24D2100-SPE2DB25FBEUA
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,029.14 to AmerisourceBergen Drug Corp for the supply of Epinephrine 0.3 mg auto-injector pens (2-pack units). This firm fixed price, non-set-aside delivery order was awarded on July 30, 2025, with an ultimate completion date of July 31, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 31, 2025, for the supply of Epinephrine 0.3 mg auto-injector pens (2-pack) with a ceiling value of $3,588.71. This is a firm fixed-price delivery order with no set-aside designation, employing competitive procurement procedures. The contract is scheduled for ultimate completion on November 3, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania....
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on June 16, 2025, for the supply of Epinephrine 0.3 mg auto-injector packs valued at $2,954.20. This is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of June 17, 2025, and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The award represents a single delivery order issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for epinephrine 0.3 mg auto-injector pens (2-pack) on October 30, 2025, with a ceiling value of $1,822.41 and an ultimate completion date of October 31, 2025. This is a firm fixed-price, non-competitive delivery order placed under AmerisourceBergen's larger indefinite delivery contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The product will be...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of epinephrine 0.3 mg auto-injector pens (2-pack) on August 1, 2025, with a ceiling value of $1,380.14 and ultimate completion date of August 4, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to the pharmaceutical distributor's Conshohocken, Pennsylvania location. The contract represents a continuation of AmerisourceBergen's role as a...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for epinephrine 0.3 mg auto-injector packs (two-pack units) on June 16, 2025, with a ceiling value of $2,429.74 and ultimate completion date of June 17, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded under an existing contract vehicle. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of Epinephrine 0.3 mg auto-injector (2-pack units) with a ceiling value of $2,704.19. This competitively awarded, firm fixed-price delivery order is scheduled for completion by September 2, 2025, and will be fulfilled from the vendor's Conshohocken, Pennsylvania facility. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of epinephrine 0.3 mg auto-injector 2-packs with a ceiling value of $8,428.38. This firm fixed-price delivery order, which is non-competitive and carries an ultimate completion date of September 16, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through...
- The Defense Logistics Agency awarded a delivery order valued at $25,502.10 to AmerisourceBergen Drug Corp for the supply of Epinephrine 0.3 mg auto-injector pens (2-pack). This firm fixed price, competitively awarded contract was executed on September 26, 2025, with an ultimate completion date of September 29, 2025. The place of performance is listed as the contractor's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 25, 2025, for the supply of Epinephrine 0.15 mg auto-injectors in a two-pack configuration. This contract, valued at $11,352.44, represents a firm fixed-price delivery order under a non-set-aside competitive procurement. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office location. This...
- SPE2DB24D2100Indefinite Delivery Contract
- SPE2DB24D2100-SPE2DB25FBEUADelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Epinephrine 0.3 mg auto-injector pens (2-pack) on June 17, 2025, with a ceiling value of $13,093.78 and an ultimate completion date of June 18, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and specifies performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a wide range of pharmaceutical products and medical supplies to military healthcare systems. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, functions as a critical vendor within the federal medical procurement supply chain, particularly for military and veteran healthcare systems. The company's extensive federal contract portfolio demonstrates its capability to deliver diverse pharmaceutical commodities across multiple therapeutic domains, from specialty medications and vaccines to medical devices and auto-injectors. This specific delivery order for epinephrine auto-injectors reflects the company's role in supporting the Defense Health Agency and other government healthcare systems through flexible and competitively awarded contract vehicles under the DLA's pharmaceutical prime vendor program.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $13.1k | 6/17/25 |